NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company") is pleased to announce the formation of a U.S.-based ...

Elsewhere, cell therapy developer Turnstone Biologics announced a second round of layoffs and plans to explore “strategic ...

Precision medicines biotech Frontier Medicines is leaving behind an unknown number of staffers as it refocuses resources to ...

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

Federal regulators have warned a Waco, Texas, company that its human amniotic products are “unlicensed” and “unapproved,” and ...

These companies are often located in countries with frontier and emerging market economies. However, there are key differences to be aware of between frontier and emerging market economies.

When UFC CEO Dana White found out Khabib Nurmagomedov was removed from a Frontier Airlines flight, one thought crossed his mind. “What the f*ck is he doing on Frontier Airlines anyway?” White said in ...

10:30 a.m. ET Despite challenges in the CDMO industry, Samsung Biologics is "well positioned to kick-start a new phase of growth in 2025," CEO John Rim said in a press release ahead of his Tuesday ...